Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Prenetics Global Limited - Class A Ordinary Share (NQ: PRE ) 5.400 -0.210 (-3.74%) Streaming Delayed Price Updated: 3:59 PM EDT, Aug 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Prenetics Global Limited - Class A Ordinary Share Prenetics Global (NASDAQ: PRE): Bending Biotech with Beckham July 12, 2024 Via AB Newswire Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham July 11, 2024 From Prenetics Limited Via GlobeNewswire Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors July 01, 2024 Adding Decades of Public Company and Board Expertise as Prenetics Readies for Expansion into Consumer Health and Wellness From Prenetics Limited Via GlobeNewswire Prenetics Global Limited (NASDAQ: PRE): Genomic Innovations Making Waves in Cancer Care June 20, 2024 Via AB Newswire Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating January 25, 2023 From Prenetics Global Limited Via ACN Newswire Prenetics Announces First Quarter 2024 Financial Results June 18, 2024 From Prenetics Limited Via GlobeNewswire Prenetics Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program June 17, 2024 ~ Emphasizes Strong Cash Position, No Debt, and A Dedicated Management Team Focused on Delivering Growth and Value to Shareholders ~ From Prenetics Limited Via GlobeNewswire Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results April 01, 2024 From Prenetics Limited Via GlobeNewswire Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station February 09, 2024 From Prenetics Limited Via GlobeNewswire Prenetics Announces Third Quarter 2023 Financial Results November 20, 2023 From Prenetics Limited Via GlobeNewswire Prenetics Global Limited Announces Reverse Stock Split November 01, 2023 From Prenetics Limited Via GlobeNewswire Prenetics Announces Second Quarter 2023 Financial Results September 15, 2023 From Prenetics Limited Via GlobeNewswire Prenetics Global signs "transformational" $200mln deal to create cancer screening JV June 30, 2023 Prenetics Global Ltd (NASDAQ:PRE) CEO Danny Yeung speaks to Thomas Warner from Proactive after announcing a $200mln deal to create a multi-cancer early detection screening joint venture with Professor... Via TheNewswire.com Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening June 25, 2023 Company will Host Conference Call to Discuss the Transaction on June 26 at 8:30 a.m. EDT From Prenetics Limited Via GlobeNewswire Prenetics Announces First Quarter 2023 Financial Results June 05, 2023 From Prenetics Limited Via GlobeNewswire Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results March 14, 2023 New Business Strategy Focused on Precision Oncology From Prenetics Limited Via GlobeNewswire Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology March 02, 2023 From Prenetics Limited Via GlobeNewswire Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference February 02, 2023 From Prenetics Limited Via GlobeNewswire Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA January 19, 2023 From Prenetics Limited Via GlobeNewswire Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors January 10, 2023 From Prenetics Limited Via GlobeNewswire Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology December 16, 2022 From Prenetics Limited Via GlobeNewswire Prenetics Acquires ACT Genomics; First M&A Deal since IPO, Set to Expand Footprint in Cancer Genomics December 16, 2022 From Prenetics Global Limited Via ACN Newswire Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index November 30, 2022 From Prenetics Limited Via GlobeNewswire Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index November 30, 2022 From Prenetics Global Limited Via ACN Newswire Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance November 10, 2022 Via ACN Newswire Exposures COVID-19 Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance November 10, 2022 From Prenetics Limited Via GlobeNewswire Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook September 09, 2022 Via ACN Newswire Exposures COVID-19 Younger Colorectal Cancer Population Highlights the Importance of Early Screening, Highly Sensitive Test Product Prenetics has Launched the Market September 01, 2022 Via ACN Newswire Above Phone partners with Presearch on secure, private phone August 25, 2022 Above Phone will now ship with Presearch as default web browser and search engine. Via IssueWire Citi Initiates Coverage on Prenetics Global with "Buy" Rating, Target Price at USD8.10 July 13, 2022 Via ACN Newswire Exposures COVID-19 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.